A massive preprint study from Brazil released in December that shows low preventive dosages of ivermectin taken every two weeks reduced COVID-19 mortality by 68% is being suppressed by Twitter.
The study involved 220,517 people and was conducted in the Brazilian city of Itajaí, where all of the citizens were invited to participate. It found that the “regular use of ivermectin led to a 68% reduction in COVID-19 mortality,” in addition to a 56% lower hospitalization rate.
“These results indicate that medical-based optional prescription, citywide covered ivermectin can have a positive impact in the healthcare system,” the study’s authors concluded.
One of the nine authors, Dr. Pierre Kory of the Front Line COVID-19 Critical Care Alliance, described the study as the “world’s largest” on the repurposing of ivermectin for the treatment of COVID-19.
However, on the heels of the Brazilian study’s release, Twitter slapped a warning label on it, calling the paper “Misleading” and preventing it from being “replied to, shared or liked.”
Jennifer Cabrera, an editor of the Alachua Chronicle, retweeted another user’s promotion of the study, noting the seeming arbitrary exercise of censorship. “Wow, Twitter can’t be bothered to explain why they disagree with the methodology of this research paper. They just label it misinformation. That probably means you should read it.”Prophylacticivermectin.Updatedversion.Dec242021.